Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer (Q37891413)

24 August 2017

1 reference

title

Urine markers for detection and surveillance of non-muscle-invasive bladder cancer (English)

1 reference

24 August 2017

Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer (English)

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

4 December 2024

main subject

diagnostic reagent kit

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21684071

4 December 2024

8

Morgan Rouprêt

1 reference

24 August 2017

9

Shahrokh F Shariat

1 reference

24 August 2017

10

Alexandre R Zlotta

1 reference

24 August 2017

1

Derya Tilki

1 reference

24 August 2017

2

Maximilian Burger

1 reference

24 August 2017

Guido Dalbagni

3

1 reference

24 August 2017

Juan Palou

6

1 reference

24 August 2017

Oliver Reich

7

1 reference

24 August 2017

H. Barton Grossman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21684071

4 December 2024

Oliver W. Hakenberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21684071

4 December 2024

Shahrokh F. Shariat

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21684071

4 December 2024

language of work or name

English

0 references

publication date

12 June 2011

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:S0302283811006014?httpAccept=text/plain

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

https://api.elsevier.com/content/article/PII:S0302283811006014?httpAccept=text/xml

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

4 December 2024

1 reference

24 August 2017

volume

60

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

484-492

1 reference

Functional characterization of the bladder cancer marker, BLCA-4.

24 August 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1158/1078-0432.CCR-0455-03

Highly specific urine-based marker of bladder cancer

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.UROLOGY.2005.07.010

Cancer statistics, 2010

1

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results

4 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update

4 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses

4 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer

4 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat

4 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?

4 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer

4 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Utility of the BTA stat test kit for bladder cancer screening

4 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

The BTA stat test is nonspecific for hematuria: an experimental hematuria model

4 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies

4 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

The application of human complement factor H-related protein (BTA TRAK) in monitoring patients with bladder cancer

4 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer

4 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer

4 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma

4 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Clinical evaluation of the BTA trak assay and comparison to voided urine cytology and the bard BTA test in patients with recurrent bladder tumors

4 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Quantitative detection of human complement factor H-related protein in transitional cell carcinoma of the urinary bladder

4 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

BTA stat and BTA TRAK: A comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder

4 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?

4 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China

4 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade mark

4 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Diagnostic Utility of the ImmunoCyt/uCyt Test in Bladder Cancer

4 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

ImmunoCyt and cytokeratin 20 immunocytochemistry as adjunct markers for urine cytologic detection of bladder cancer: a prospective study

4 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract

4 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma

4 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence

4 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study

4 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Urinary nuclear matrix protein 22 (NMP22): a diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder

4 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria

4 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Comparison of screening methods in the detection of bladder cancer

4 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder

4 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Role of urinary NMP-22 combined with urine cytology in follow-up surveillance of recurring superficial bladder urothelial carcinoma

4 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Detection of bladder cancer using a point-of-care proteomic assay

4 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis

4 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Analysis of genetic alterations in normal bladder urothelium.

4 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?

4 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Vysis UroVysion for the detection of urothelial carcinoma

4 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing

4 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology

4 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer

4 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer

4 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology

4 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples

4 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection

4 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Use of the novel marker BLCA-1 for the detection of bladder cancer

4 December 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4

4 December 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

CEACAM1: a novel urinary marker for bladder cancer detection

4 December 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer

4 December 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients

4 December 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.

4 December 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection

4 December 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract

4 December 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples

4 December 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine

4 December 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer.

4 December 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer

4 December 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade

4 December 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

ELEVATED TISSUE EXPRESSION OF HYALURONIC ACID AND HYALURONIDASE VALIDATES THE HA-HAase URINE TEST FOR BLADDER CANCER

4 December 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison

4 December 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial

4 December 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer

4 December 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Allelotype of human bladder cancer

4 December 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis

4 December 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer tr

4 December 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

4 December 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

4 December 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

4 December 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Distinct microRNA alterations characterize high- and low-grade bladder cancer

4 December 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Survivin: a promising biomarker for detection and prognosis of bladder cancer

4 December 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas.

4 December 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer

4 December 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Urine detection of survivin and diagnosis of bladder cancer

4 December 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.

4 December 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Clinical experience with survivin as a biomarker for urothelial bladder cancer

4 December 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Structure and function of telomeres

4 December 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Telomere length regulation

4 December 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats

4 December 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

4 December 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas

4 December 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker

4 December 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise

4 December 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity

4 December 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes

4 December 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Telomerase activity in malignant and benign bladder conditions

4 December 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer

4 December 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence

4 December 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma

4 December 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Clinical application of NMP22 and urinary cytology in patients with hematuria or a history of urothelial carcinoma

4 December 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.

4 December 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer

4 December 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder.

4 December 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Comparison of two qualitative assays, the UBC rapid test and the BTA stat test, in the diagnosis of urothelial cell carcinoma of the bladder

4 December 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Qualitative and Quantitative Detection of Urinary Human Complement Factor H-Related Protein (BTA stat and BTA TRAK) and Fragments of Cytokeratins 8, 18 (UBC Rapid and UBC IRMA) as Markers for Transitional Cell Carcinoma of the Bladder

4 December 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma

4 December 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Considerations on implementing diagnostic markers into clinical decision making in bladder cancer

4 December 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).

4 December 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Challenges of cancer biomarker profiling

4 December 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients

4 December 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.053

4 December 2024

Identifiers

1 reference

24 August 2017

1 reference